NOVUGEN ONCOLOGY

Classification: Manufacturer (Factory)

Company Overview:

Novugen Oncology is a highly advanced pharmaceutical company based in Malaysia, specializing in the research, development, and manufacturing of high-quality, affordable oncology (cancer) medicines. It operates as a subsidiary of the SciTech Group, a global pharmaceutical entity.

Business Type:

Novugen Oncology is a Manufacturer (Factory). The company owns and operates a state-of-the-art, fully integrated research and development (R&D) center and sterile manufacturing facility in Bandar Enstek, Negeri Sembilan, Malaysia.

Key Facilities and Capabilities:

The company's manufacturing plant is designed to meet stringent global regulatory standards, including those of the US Food and Drug Administration (USFDA), European Medicines Agency (EMA), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). The facility features advanced containment technologies to safely produce highly potent active pharmaceutical ingredients (HPAPIs), specializing in oncology oral solids and sterile injectables.

Product Focus:

Novugen focuses on producing a comprehensive range of oncology therapeutics, aiming to make critical cancer treatments more accessible and affordable to patients worldwide, addressing the global demand for niche and complex generic oncology drugs.

Mission and Vision:

Novugen is dedicated to enhancing global healthcare by providing life-saving oncology treatments through cutting-edge technology, rigorous quality control, and world-class manufacturing standards.

Novugen Oncology, based in Malaysia, specializes in the research, development, and manufacturing of high-potency oncology medicines. Their product portfolio includes both oral solid dosages and sterile injectables (liquid and lyophilized vials) for cancer treatment.

Below is the list of products manufactured or sold by Novugen Oncology:

Oral Solid Dosages (Tablets and Capsules)

1. Abiraterone Acetate

Used for the treatment of metastatic castration-resistant prostate cancer.

2. Temozolomide

Used for the treatment of brain tumors, including glioblastoma multiforme and anaplastic astrocytoma.

3. Imatinib

Used for chronic myeloid leukemia and gastrointestinal stromal tumors.

4. Gefitinib

Used for the treatment of non-small cell lung cancer.

5. Erlotinib

Used for non-small cell lung cancer and pancreatic cancer.

6. Capecitabine

Used for breast, colorectal, and colon cancers.

7. Lenalidomide

Used for multiple myeloma and myelodysplastic syndromes.

Injectable Formulations (Liquid and Lyophilized Vials)

8. Bortezomib

Used for multiple myeloma and mantle cell lymphoma.

9. Pemetrexed

Used for non-small cell lung cancer and malignant pleural mesothelioma.

10. Paclitaxel

Used for breast, ovarian, and lung cancers.

11. Docetaxel

Used for breast, lung, prostate, stomach, and head and neck cancers.

12. Gemcitabine

Used for pancreatic, breast, ovarian, and non-small cell lung cancers.

13. Carboplatin

Used for advanced ovarian cancer and other cancer types.

14. Oxaliplatin

Used for colorectal cancer.

Active Pharmaceutical Ingredients (APIs)

Novugen also develops and manufactures High-Potency Active Pharmaceutical Ingredients (HPAPIs) in-house to support their finished dosage formulations, ensuring supply chain security and quality control.